Key Drivers
- Interest Coverage
- Margin Pressure
- Debt Burden
AIAI Summary
SGRY should be viewed less as a cheap healthcare stock and more as a leveraged outpatient surgery platform whose rerating hinges on converting resilient same-facility growth into sustained free cash flow and materially better interest coverage, because the current valuation only works if margins stabilize before heavy debt and cost pressure erode earnings quality.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Interest Coverage
- •Margin Pressure
- •Debt Burden
SGRY generated solid annual cash flow but weakening quarterly margins, persistent losses, and heavy debt/interest burden leave its earnings and balance sheet outlook fragile.
Price Behavior
Key Price Behavior Insights:
- •Breakout trend
- •Overextended run
- •Nearby support
SGRY has broken out into a strong last month uptrend, but after a ~28% run it looks stretched and may pause or consolidate near $16.56-$16.80.
Rapid ~28% rise from $13.51 to $17.23 over last month suggests short-term volatility risk
Sentiment & News
Key News Insights:
- •Analyst Upside
- •Improving Estimates
- •Scale Advantage
Surgery Partners is attracting constructive attention as a reasonably priced momentum stock, backed by analyst upside, improving estimates, and its large outpatient care network.
The latest headlines likely reinforce investor confidence in SGRY by highlighting both valuation appeal and operational scale
Similar Companies in Healthcare
Other companies in the same sector with AI ratings